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Abstract
A one-pot, sequential protocol is reported that involves complementary ambiphile pairing (CAP)
of a vinyl sulfonamide with a variety of unprotected amino acids via aza-Michael addition and
subsequent intramolecular amidation. The method generates diverse, sp3-rich mono- and bicyclic
acyl sultams in a highly scalable manner. Modular pairing of stereochemically rich building
blocks allows quick access to all possible isomers. Extension to include one-pot, sequential 3-, 4-
and 5-multicomponent protocols is also discussed.
Acyl sultams are unnatural compounds that possess unique physical and chemical properties
rendering them attractive targets for probing biological systems. In this regard, a number of
bioactive acyl sulfonamides/sultams have been reported that encompass a variety of
activities, including antibacterial, anticancer, and antiinflammatory properties, as well as
unique biological profiles in different cell assays as highlighted in Figure 1.1 While the
synthesis of acyl sulfonamides/benzofused sultams are well documented in the literature,1 to
the best of our knowledge reports of non-benzofused, 7-membered acyl sultams bearing
stereogenic centers are relatively void in the literature. We herein report a complementary
ambiphilic pairing (CAP) strategy, vide infra, employing vinyl sulfonamides and
unprotected amino acids in a one-pot, sequential aza-Michael addition/intramolecular
amidation reaction (formally a [4+3] heterocyclization) for the generation of skeletally and
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stereochemically diverse, sp3-rich 2 mono- and bicyclic acyl sultams. Extension of the
method to include a one-pot, sequential 3-, 4- and 5-multicomponent protocols is also
discussed.
The rapid generation of functionally diverse small molecule collections for high throughput
screening, is an important aspect of modern drug discovery. In particular, the development
of multicomponent, one-pot reaction strategies that allow for facile assembly of heterocyclic
scaffolds, with minimum purification is particularly desirable. 3 Diversity-oriented synthesis
(DOS) has emerged as a powerful strategy for systematically probing biological space aimed
at uncovering novel leads. 4 Among several approaches, the build-couple-pair5a and
functional group pairing5b strategies have featured prominently in advancing DOS. We
recently reported the concepts of complementary ambiphile pairing (CAP)6 and reaction
pairing 7 as DOS strategies for the facile generation of diverse sultam scaffolds. In this
regard, the complementary union of ambiphilic 8 synthons, in a formal [m+n] fashion ([4+3]
and [4+4]), allows access to diverse cyclic heterocycles in a step-economical approach.9 It
was envisioned that the unification of CAP and multicomponent, one-pot protocols would
provide a library amenable methodology to access the titled sp3-rich2 7-membered acyl
sultams.
The method was premised on the ambiphilic nature of both vinyl sulfonamides and amino
acids. In this regard, the ambiphilic nature of vinyl sulfonamides were previously reported to
readily undergo hetero-Michael additions as well as N-alkylations,10 and participate in a
[4+3] epoxide-opening/Michael protocol.6a Likewise, amino acids can be conceptually
classified as ambiphilic synthons where they represent ideal starting materials as they allow
for encoding stereochemical, skeletal and peripheral diversity. Furthermore, while aza-
Michael addition of unprotected amino acids to acrylonitrile,11 acrylate esters, 12
acrylaldehyde, 13 sulfones, 14 and vinylphosphoryl compounds15 have been reported, to the
best of our knowledge aza-Michael addition of unprotected amino acids to vinyl
sulfonamides are absent in the literature.
The investigation commenced with the Michael addition of trans-3-hydroxy-(L)-proline (8a)
to N-propargylic vinyl sulfonamide in the presence of 0.2 equivalents of DBU. Initially, both
MeOH and CH3CN were probed as solvents with overnight stirring at 60 °C (Table 1, entry
2). However, these preliminary conditions failed to furnish the corresponding product.
Changing the base to Et3N generated the product in moderate yield, however, utilizing a 1:1
mixture of MeOH/H2O as the solvent with Et3N as base cleanly afforded the desired
Michael adduct. The reaction mixture was concentrated to dryness, and subsequent
resolvation of the reaction mixture with DMF and addition of EDC, HOBt and Et3N with
overnight stirring, afforded the desired bicyclic acyl sultam 10e in 64% yield.
The substrate scope and the scalability of this protocol were next investigated (Table 1). The
reaction was pleasingly found to work well with a variety of alkyl- and benzyl amine-
derived vinyl sulfonamides to furnish the desired products in good to excellent yields on
multigram scales. It is noteworthy that this one-pot protocol was shown to be scalable to
produce 28 grams of 10e (64% isolated yield). Also significant, is the ability to utilize a
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hydroxy-functionalized amino acid without the need for any protection in the Michael
addition step (Table 1).
This strategy was further extended to bicyclic acyl sultams using a variety of cyclic amino
acids. Notable applications include a azetidine 2-carboxylic acid, (R)-thiazolidine-4-
carboxylic acid, 2-(pyrrolidin-2-yl)acetic acid and morpholine 3-carboxylic acid to afford
the 4,7-fused, 5,7-fused, 5,8-fused, and 6,7-fused bicyclic systems, respectively (Scheme 1).
Investigations were next focused on a modular approach using chiral amino ester-derived
vinyl sulfonamides, as this would allow for the generation of stereochemically rich libraries2
by a simple change in the amino acid/amino ester pair. Hence, (L)-alanine tert-butyl ester-
derived vinyl sulfonamide was subjected to the established one-pot, CAP protocol
employing (D)- and (L)-proline affording the acyl sultams (18, 19) without decomposition of
the ester (Scheme 1). Use of the enantiomers of α-methylbenzylamine-derived vinyl
sulfonamides, 20 and 21, together with both L-trans- and D-cis-hydroxyproline in the
aforementioned method, gratifyingly furnished a collection of four diastereoisomers in good
yields without any signs of racemization (Scheme 2).
The methodology was further extended to acyclic amino acids with a variety of N-
substituted vinyl sulfonamides utilizing the same protocol (Table 2). Amino acids bearing
alkyl side chains (leucine, isoleucine, valine and alanine) gave good yields in a highly
scalable manner. The reaction conditions also tolerated amino acids with nucleophilic side
chains (trifunctional amino acids) such as tyrosine and cysteine, which reacted well albeit in
lower yields.
We next set out to extend the method to a one-pot, sequential protocol by increasing the
number of reactions that could be carried out before chromatographic intervention.3a-d Thus,
2-chloroethane sulfonyl chloride was sulfonylated with benzyl amine utilizing Et3N (2.0
equiv) and upon completion of reaction, the mixture was concentrated to dryness. Subjection
of the crude sulfonamide to the established one-pot, aza-Michael addition–intramolecular
amidation with a variety of cyclic amino acids, furnished the desired products in 39–85%
final isolated yields (Scheme 3). This one-pot, sequential 3-component protocol was also
found to work with acyclic amino acids (DMF was the preferred solvent for cyclic amino
acids, while CHCl3 at 50 °C was used for acyclic amino acids) to furnish the corresponding
acyl sultams in moderate to good overall yields.
Encouraged with the above results, efforts were focused toward the extension of the method
to a one-pot, sequential, 4-component reaction protocol using variable pathways (Scheme 4).
Thus, four reactions were setup using the one-pot sulfonylation–aza-Michael–intramolecular
amidation sequence with propargyl amine and trans-3-hydroxy-(L)-proline. Upon
completion of the four parallel procedures, a fourth component, cyclohexyl isocyanate, was
added to the first crude reaction mixture to furnish the desired carbamate 28 in 37% yield
after chromatography (78% avg/rxn). The second reaction mixture was concentrated to
dryness, and a subsequent click reaction was carried out with the fourth component, 4-
methylbenzyl azide, to generate the corresponding triazoylated thiadiazepin-1(2H)-one-3,3-
dioxide 29 in 45% yield after chromatography (82% avg/rxn). To the third crude reaction, an
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esterification was performed with the fourth component, 4-methyl benzoic acid, to afford the
corresponding acyl sultam 30 in 42% yield after chromatography (81% avg/rxn).
Building upon these results, the highly functionalized sultam scaffold 31 was constructed via
a one-pot, sequential, 5-component reaction sequence (Scheme 4). Thus, to the fourth
reaction mixture, esterification with 4-methyl benzoic acid (fourth component), and
subsequent click reaction with 4-methylbenzyl azide (fifth component) produced the desired
triazolyl esterified [1,2,5]thiadiazepin-1(2H)-one-3,3-dioxide 31 in 35% yield (81% avg/
rxn).
In conclusion, we have developed a highly scalable, one-pot, CAP reaction employing vinyl
sulfonamides and amino acids for the preparation of skeletally, stereochemically and
peripherally diverse sp3-rich sultam scaffolds containing an acylsulfonamide functionality.
This approach was extended to various one-pot, sequential 3-, 4- and 5-component reaction
protocols to afford thiadiazepin-1(2H)-one-3,3-dioxide scaffolds with high peripheral ligand
diversity. Furthermore, the methodology is highly divergent and is eminently adaptable for
the preparation of stereochemically-rich sultam libraries. Work in this regard is underway
and will be reported in due course.
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One-pot, sequential [4+3] CAP strategy to generate bicyclic sultams with an array of cyclic
amino acids.
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Generation of stereochemical diversity.
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One-pot, sequential 3-component protocol.
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One-pot, sequential 4/5-component reaction to stereochemically-rich sultams.
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Table 1
Scope and scale-up.
entry R scale 10 yield %a
1 Bn 0.2 g NR 0b
2 propargyl 0.2 g NR 0b
3 n-butyl 2 g 10a 67c
4 4-OMe-Bn 1 g 10b 72c
5 allyl 12 g 10c 86c
6 Bn 12 g 10d 76c
7 propargyl 28 g 10e 64c
a
Final isolated yield after flash chromatography.
b
Conditions: DBU (0.2 equiv) in MeOH or DBU (0.2 equiv) in MeCN.
c
Aza-Michael: 8a (1.0 equiv), Et3N (3.0 equiv), MeOH/H2O (0.5 M, 1:1), 60 °C, 12 h. Amidation: EDC (2.0 equiv), HOBt (0.2 equiv), Et3N
(2.0 equiv), DMF (0.05 M), rt, 14 h.
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Table 2
Substrate scope - acyclic amino acids.
entry R1 R2 26 yield %a
1 Ph iBu 26a 63
2 4-F-Ph sec-Bu 26b 65
3 4-F-Ph iPr 26c 67
4 4-Cl-Ph Me 26d 65
5 (CH2)6CH3 CH2SH 26e 33
6 Ph (4-OH)-Bn 26f 41
a
Final isolated yield after flash chromatography.
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